Local salsolinol modulates dopamine extracellular levels from rat nucleus accumbens: Shell/core differences

Neurochemistry International

Volumn 55, Issue 4, 2009, Pages 187-192

  Hipólito, Lucía ^a   Sánchez Catalán, María José ^a   Granero, Luis ^a   Polache, Ana ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Alcohol addiction; Dopamine; Microdialysis; Salsolinol; The core and shell of nucleus accumbens

Indexed keywords

ACETALDEHYDE; DOPAMINE; SALSOLINOL;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSATE; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; ONLINE ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY;

ACETALDEHYDE; ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ALCOHOLISM; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ETHANOL; EXTRACELLULAR FLUID; ISOQUINOLINES; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; REWARD; SYNAPTIC TRANSMISSION; UP-REGULATION;

RATTUS; RATTUS NORVEGICUS;

EID: 67349275980     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.02.014     Document Type: Article

References (44)

1. Antkiewicz-Michaluk L., Michaluk J., Romanska I., Papla I., and Vetulani J. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol. J. Neural Transm. 107 (2000) 1009-1019
2. Antkiewicz-Michaluk L., Romanska I., Papla I., Michaluk J., Bakalarz M., Vetulani J., Krygowska-Wajs A., and Szcudlik A. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain. Neuroscience 96 (2000) 59-64
3. Antkiewicz-Michaluk L. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines. Pol. J. Pharmacol. 54 (2002) 567-572
4. Baum S.S., Hill R., Kiianmaa K., and Rommelspacher H. Effect of ethanol on (R)- and (S)-salsolinol, salsoline, and THP in the nucleus accumbens of AA and ANA rats. Alcohol 18 (1999) 165-169
5. Cano-Cebrián M.J., Zornoza T., Polache A., and Granero L. Quantitative in vivo microdialysis in pharmacokinetic studies: some reminders. Curr. Drug. Metab. 6 (2005) 83-90
6. Cohen G., and Collins M. Alkaloids from catecholamines in adrenal tissue: possible role in alcoholism. Science 167 (1970) 1749-1751
7. Davis V.E., and Walsh M.J. Alcohol, amines, and alkaloids: a possible biochemical basis for alcohol addiction. Science 167 (1970) 1005-1007
8. Deng Y., Maruyama W., Yamamura H., Kawai M., Dostert P., and Naoi M. Mechanism of enantioseparation of salsolinols, endogenous neurotoxins in human brain, with ion-pair chromatography using beta-cyclodextrin as a mobile phase additive. Anal. Chem. 68 (1996) 2826-2831
9. Dostert P., Strolin-Benedetti M., and Dordain G. Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases. J. Neural Transm. 74 (1988) 61-74
10. Duncan C., and Deitrich R.A. A critical evaluation of tetrahydroisoquinoline induced ethanol preference in rats. Pharmacol. Biochem. Behav. 13 (1980) 265-281
11. Gudelsky G.A., and Yamamoto B.K. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotoninergic and cholinergic neurons. Pharmacol. Biochem. Behav. 90 (2008) 198-207
12. Haber H., Dumaual N., Bare D.J., Melzig M.F., McBride W.J., Lumeng L., and Li T.K. The quantitative determination of R- and S- salsolinol in the striatum and adrenal gland of rats selectively bred for disparate alcohol drinking. Addict. Biol. 4 (1999) 181-189
13. Hashimoto K., Nakahara T., Yamada H., Hirano M., Kuroki T., and Kanba S. A neurotoxic dose of methamphetamine induces gene expression of Homer 1a, but not Homer 1b or 1c, in the striatum and nucleus accumbens. Neurochem. Int. 51 (2007) 227-232
14. Hernández L.F., Segovia G., and Mora F. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat. Neurochem. Int. 52 (2008) 457-469
15. Hipólito L., Sánchez-Catalán M.J., Zanolini I., Polache A., and Granero L. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens. Neuropharmacology 55 (2008) 183-189
16. Hirose N., Murakawa K., Takada K., Oi Y., Suzuki T., Nagase H., Cools A.R., and Koshikawa N. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience 135 (2005) 213-225
17. Homicskó K.G., Kertész I., Radnai B., Tóth B.E., Tóth G., Fülöp F., Fekete M.I., and Nagy G.M. Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat. Neurochem. Int. 42 (2003) 19-26
18. Jantas D., Pytel M., Mozrzymas J.W., Leskiewicz M., Regulska M., Antkiewicz-Michaluk L., and Lason W. The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem. Int. 52 (2008) 864-877
19. McKittrick C.R., and Abercrombie E.D. Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core. J. Neurochem. 100 (2007) 1247-1256
20. Matsubara K., Fukushima S., and Fukui Y. A systematic regional study of brain salsolinol levels during and immediately following chronic ethanol ingestion in rats. Brain Res. 413 (1987) 336-343
21. Matsuzawa S., Suzuki T., and Misawa M. Involvement of mu-opioid receptor in the salsolinol-associated place preference in rats exposed to conditioned fear stress. Alcohol Clin. Exp. Res. 24 (2000) 366-372
22. Mravec B. Salsolinol, a derivate of dopamine, is a possible modulator of catecholamiergic transmission: a review of recent developments. Physiol. Res. 55 (2006) 353-364
23. Melchior C.L., and Myers R.D. Preference for alcohol evoked by tetrahydropapaveroline (THP) chronically infused in the cerebral ventricle of the rat. Pharmacol. Biochem. Behav. 7 (1977) 19-35
24. Myers W.D., Mackenzie L., Ng K.T., Singer G., Smythe G.A., and Duncan M.W. Salsolinol and dopamine in rat medial basal hypothalamus after chronic ethanol exposure. Life Sci. 36 (1985) 309-314
25. Myers R.D. Tetrahydroisoquinolines and alcoholism: where are we today?. Alcohol Clin. Exp. Res. 20 (1996) 498-500
26. Myers R.D., and Robinson D.E. Tetrahydropapaveroline injected in the ventral tegmental area shifts dopamine efflux differentially in the shell and core of nucleus accumbens in high-ethanol-preferring (HEP) rats. Alcohol 18 (1999) 83-90
27. Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29 (1997) 99-111
28. Naoi M., Maruyama W., Dostert P., and Hashizume Y. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease. J. Neural Transm. 50 (1997) 89-105
29. Naoi M., Maruyama W., and Nagy G.M. Dopamine-derived salsolinol derivates as endogenous monoamine oxidase inhibitors: ocurrence, metabolism and function in human brains. Neurotoxicology 25 (2004) 193-204
30. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
31. Quarta D., Di Francesco C., Melotto S., Mangiarini L., Heidbreder C., and Heodu G. Systemic administration of ghrelin increases extracellulat dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem. Int. 54 (2009) 89-94
32. Rodd Z.A., Bell R.L., Zhang Y., Goldstein A., Zaffaroni A., McBride W.J., and Li T.K. Salsolinol produces reinforcing effects in the nucleus accumbens shell of alcohol-preferring (P) rats. Alcohol Clin. Exp. Res. 27 (2003) 440-449
33. Rodd Z.A., Oster S.M., Ding Z.M., Toalston J.E., Deehan G., Bell R.L., Li T.K., and McBride W.J. The reinforcing properties of salsolinol in theventral tegmental area: evidence for regional heterogeneity and the involvement of serotonin and dopamine. Alcohol Clin. Exp. Res 32 (2008) 230-239
34. Rojkovicova T., Mechref Y., Starkey J.A., Wu G., Bell R.L., McBride W.J., and Novotny M.V. Quantitative chiral analysis of salsolinol in different brain regions of rats genetically predisposed to alcoholism. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 863 (2008) 206-214
35. Rommelspacher H., Baum S., Dufeu P., and Schmidt L.G. Determination of (R)- and (S)-salsolinol sulfate and dopamine sulfate levels in plasma of nonalcoholics and alcoholics. Alcohol 12 (1995) 309-315
36. Santiago M., and Westerink B.H. Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn Schmiedebergs Arch. Pharmacol. 342 (1990) 407-414
37. Székács D., Bodnár I., Mravec B., Kvetnansky R., Vizi E.S., Nagy G.M., and Fekete M.I.K. The peripheral noradrenergic terminal as possible site of action of salsolinol as prolactoliberin. Neurochem. Int. 50 (2007) 427-434
38. Székács D., Bodnár I., Vizi E.S., Nagy G.M., and Fekete M.I.K. The role of catecholamines in the prolactin release induced by salsolinol. Neurochem. Int. 51 (2007) 319-322
39. Sjoquist B., Liljequist S., and Engel J. Increased salsolinol levels in rat striatum and limbic forebrain following chronic ethanol treatment. J. Neurochem. 39 (1982) 259-262
40. Starkey J.A., Mechref Y., Muzikar J., McBride W.J., and Novotny M.V. Determination of salsolinol and related catecholamines through on-line preconcentration and liquid chromatography/atmospheric pressure photoionization mass spectrometry. Anal. Chem. 78 (2006) 3342-3347
41. Storch A., Ott S., Hwang Y.I., Ortmann R., Hein A., Frenzel S., Matsubara K., Ohta S., Wolf H.U., and Schwarz J. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter. Biochem. Pharmacol. 63 (2002) 909-920
42. Tóth B.E., Bodnár I., Homicskó K.G., Fülöp F., Fekete M.I., and Nagy G.M. Physiological role of salsolinol: its hypophysiotrophic function in the regulation of pituitary prolactin secretion. Neurotoxicol. Teratol. 24 (2002) 655-666
43. Voorn P., Vanderschuren L., Groenewegen H., Robbins T., and Pennartz C. Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 27 (2004) 468-474
44. Zahm D.S. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci. Biobehav. Rev. 24 (2000) 85-105